MAINE MEDICAL CENTER
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Feb 13, 2018 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 527 Total Citation Count
- Apr 10, 1995 Earliest Filing
- 26 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0240,638 ENHANCING THE THERAPEUTIC ACTIVITY OF IMMUNE CHECKPOINT INHIBITORFeb 17, 17Aug 24, 17[A61K, C07K]
2017/0065,716 ENHANCING THE THERAPEUTIC ACTIVITY OF AN IMMUNE CHECKPOINT INHIBITORJun 01, 16Mar 09, 17[A61K, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9890208 Compositions and methods for treating inflammation and fibrosisSep 17, 14Feb 13, 18[A61K, C07K]
9220746 Compounds and methods for treating bone disorders and controlling weightJun 04, 10Dec 29, 15[A61K, A61P, C07K]
9050296 Methods for treating metabolic syndrome with Cthrc1 polypeptideJul 03, 13Jun 09, 15[A61K, G01N, A01K, A61P, C07K]
8710099 Treatment of cancer using the sodium salt of a benzoic acid derivativeSep 10, 10Apr 29, 14[A61K, C07C]
8349559 System and method for identifying erythropoietin-responsive genesJan 25, 10Jan 08, 13[C12Q, G01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0237,504 COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND FIBROSISAbandonedOct 14, 10Sep 20, 12[A61K, A61P]
8173613 Modulation of mesenchymal and metastatic cell growthExpiredSep 22, 06May 08, 12[A61K, C07H, C12N]
7541431 Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating theretoExpiredAug 17, 06Jun 02, 09[C07K]
2009/0123,565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating theretoAbandonedMay 22, 06May 14, 09[A61K]
7501281 Compositions, methods and kits related to thrombin, Notch signaling and stamatogenesis and growth of stem cellsExpiredAug 22, 05Mar 10, 09[C12N]
2008/0193,942 System and method for identifying erythropoietin-responsive genesAbandonedNov 06, 07Aug 14, 08[C12Q, C12N, G01N]
2008/0172,214 System For Optimizing Treatment Strategies Using a Patient-Specific Rating SystemAbandonedAug 26, 05Jul 17, 08[G06Q, G06G]
7304138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acidsExpiredAug 28, 03Dec 04, 07[C07K]
2006/0084,599 Compositions, methods and kits relating to notch signalingAbandonedFeb 10, 05Apr 20, 06[A61K, C07K]
6982170 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1ExpiredDec 17, 01Jan 03, 06[C12N]
2005/0147,602 Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrixAbandonedSep 10, 04Jul 07, 05[C07H, A61K, A01K, C07K]
6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acidsExpiredAug 06, 02Nov 30, 04[C07H, C12P, C12N]
2004/0229,796 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating theretoAbandonedFeb 23, 04Nov 18, 04[A61K]
2004/0203,018 Compositions and methods relating to control DNA constructAbandonedAug 14, 03Oct 14, 04[C07H, C12Q]
2004/0071,787 Pharmacologic, therapeutic and diagnostic regulation of FGF-1 exportAbandonedMar 06, 03Apr 15, 04[A61K]
6716974 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acidsExpiredMay 24, 00Apr 06, 04[C07H]
2004/0063,176 Compositions, methods and kits relating to remodelAbandonedAug 04, 03Apr 01, 04[C07H, C12P, C12N]
6607911 Compositions and methods relating to control DNA constructExpiredMay 25, 01Aug 19, 03[C07H, C12Q, C12P, C12N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
